Skip to main content
Premium Trial:

Request an Annual Quote

In Print: Last Week's Pharmacogenomics Papers of Note


Circulating microRNA-21 as noninvasive predictive biomarker for response in cancer immunotherapy.
Wang Z, Han J, Cui Y, et al.
Med Hypotheses. 2013 May 10 [Epub ahead of print]

Processed B-Type Natriuretic Peptide Is a Biomarker of Postinterventional Restenosis in Ischemic Heart Disease.
Fujimoto H, Suzuki T, Aizawa K, et al.
Clin Chem. 2013 May 13. [Epub ahead of print]

Challenges and limitations in interpretation of systematic reviews: Making sense of clopidogrel and CYP2C19 pharmacogenetics.
Sorich MJ, Polasek TM, Wiese MD.
Clin Pharmacol Ther. 2013 May 13. [Epub ahead of print]

Platform comparisons for identification of breast cancers with a BRCA-like copy number profile.
Schouten PC, van Dyk E, Braaf LM, et al.
Breast Cancer Res Treat. 2013 May 14. [Epub ahead of print]

Evaluation of Heart Failure Biomarker Tests: A Survey of Statistical Considerations.
De A, Meier K, Tang R, Li M, et al.
J Cardiovasc Transl Res. 2013 May 14. [Epub ahead of print]

Preclinical discovery of candidate genes to guide pharmacogenetics during phase I development: the example of the novel anticancer agent ABT-751.
Innocenti F, Ramírez J, Obel J, et al.
Pharmacogenet Genomics. 2013 May 10. [Epub ahead of print]

Gene-expression differences in peripheral blood between lithium responders and non-responders in the Lithium Treatment-Moderate dose Use Study (LiTMUS).
Beech RD, Leffert JJ, Lin A, et al.
Pharmacogenomics J. 2013 May 14. [Epub ahead of print]

A microarray-based gene expression analysis to identify diagnostic biomarkers for unknown primary cancer.
Kurahashi I, Fujita Y, Arao T, et al.
PLoS One. 2013 May 9;8(5):e63249.

Pharmacogenetics in clinical practice: how far have we come and where are we going?
Johnson JA.
Pharmacogenomics. 2013 May;14(7):835-43.

Lung cancer in never-smokers. Does smoking history matter in the era of molecular diagnostics and targeted therapy?
Ou SH.
J Clin Pathol. 2013 May 9. [Epub ahead of print]

The prognostic role of KRAS, BRAF, PIK3CA and PTEN in colorectal cancer.
Eklöf V, Wikberg ML, Edin S, et al.
Br J Cancer. 2013 May 9. [Epub ahead of print]